APA

Iasonos A., Gounder M., Spriggs D. R., Gerecitano J. F., Hyman D. M., Zohar S. & O'Quigley J. (20130503). The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Iasonos Alexia, Gounder Mrinal, Spriggs David R, Gerecitano John F, Hyman David M, Zohar Sarah and O'Quigley John. 20130503. The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Iasonos A., Gounder M., Spriggs D. R., Gerecitano J. F., Hyman D. M., Zohar S. and O'Quigley J. (20130503). The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Iasonos Alexia, Gounder Mrinal, Spriggs David R, Gerecitano John F, Hyman David M, Zohar Sarah and O'Quigley John. The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20130503.